Product
Prevnar13
1 clinical trial
1 indication
Indication
Multiple MyelomaClinical trial
A Randomized, Double-blind, Placebo-Controlled Phase II Trial of an Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete RemissionStatus: Active (not recruiting), Estimated PCD: 2024-01-02